retatrutide obesity trial just delivered the most powerful weight loss data ever recorded in a Phase 3 trial. At 104 weeks, participants on the 12 mg dose lost an average of 85 pounds Retatrutide, a TRIPLE agonist (GLP1,
Pay in 4 interest-free payments of $7.15 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 25 - Sep 30


























